![]() |
RELATED RESOURCES |
SEC Filings:SYRSSYROS PHARMACEUTICALS INC0.8914
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2022 | Form SC 13G | Beneficial Ownership Statement | 02/11/2022 | N/A |
Form SC 13G/A | Beneficial Ownership Statement | 02/11/2022 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 02/09/2022 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 02/04/2022 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 02/03/2022 | N/A | |
Form 8-K* | Current Report* | 01/10/2022 | 01/10/2022 | |
Form 4 | Insider Transaction | 01/06/2022 | 01/05/2022 | |
2021 | Form 10-Q* | Quarterly Report* | 11/05/2021 | 09/30/2021 |
Form 3 | Insider Initial Filing | 10/13/2021 | 10/12/2021 | |
Form 4 | Insider Transaction | 10/13/2021 | 10/12/2021 | |
Form 8-K* | Current Report* | 10/13/2021 | 10/12/2021 | |
Form 3 | Insider Initial Filing | 09/28/2021 | 09/27/2021 | |
Form 4 | Insider Transaction | 09/28/2021 | 09/27/2021 | |
Form 8-K* | Current Report* | 09/20/2021 | 09/20/2021 | |
Form 3 | Insider Initial Filing | 09/10/2021 | 09/09/2021 |